RxDoctor Payments Data

Mary Engelhardt

Gynecologic Oncology · Henderson, NVNPI 1972067668

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.8% of the total across 91 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AbbVie at 43.2% of the total. Reporting peaked in 2022 at $560 and has fallen 96.6% since, to $19 in 2025.

$1,626in general payments, 2019–2025

Across 91 payments — averaging $17.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$702
  • Astellas Pharma US Inc$177
  • Daiichi Sankyo Inc.$143
  • Pfizer$83
  • Mayne Pharma Commercial LLC$75
  • Therapeuticsmd, Inc.$66
  • plus $381 from 15 others

What the payments were for

  • Food & beverage$1,60799%
  • Education$191%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

Too few gynecologic oncology providers in Nevadato place this figure against a meaningful peer group, so we don't.

Other gynecologic oncology in Henderson

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →